Clean Yield Group’s GSK GSK Stock Holding History

Clean Yield Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.94M	Buy	161,978 +621	+0.4%	+$33.7K	2.52%	6
2025 Q4	$7.91M	Sell	161,357 -2,435	-1%	-$114K	2.2%	6
2025 Q3	$7.07M	Sell	163,792 -3,596	-2%	-$140K	2%	10
2025 Q2	$6.43M	Sell	167,388 -11,726	-7%	-$448K	1.92%	10
2025 Q1	$6.94M	Sell	179,114 -20,949	-10%	-$767K	2.26%	8
2024 Q4	$6.77M	Sell	200,063 -3,656	-2%	-$132K	2.15%	9
2024 Q3	$8.33M	Sell	203,719 -6,845	-3%	-$280K	2.64%	6
2024 Q2	$8.11M	Sell	210,564 -1,878	-0.9%	-$79K	3.03%	4
2024 Q1	$9.11M	Sell	212,442 -989	-0.5%	-$40.8K	3.54%	2
2023 Q4	$7.91M	Buy	213,431 +5,692	+3%	+$204K	3.33%	3
2023 Q3	$7.8M	Buy	207,739 +2,374	+1%	+$84.3K	3.46%	4
2023 Q2	$7.32M	Buy	205,365 +7,205	+4%	+$258K	3.01%	4
2023 Q1	$7.05M	Buy	198,160 +10,432	+6%	+$365K	3%	4
2022 Q4	$6.6M	Sell	187,728 -10,111	-5%	-$337K	2.83%	4
2022 Q3	$5.82M	Buy	197,839 +30,873	+18%	+$1.17M	2.7%	6
2022 Q2	$9.09M	Sell	166,966 -7,664	-4%	-$423K	3.76%	2
2022 Q1	$9.51M	Buy	174,630 +1,944	+1%	+$106K	3.36%	2
2021 Q4	$9.52M	Buy	172,686 +1,808	+1%	+$94.1K	3.04%	4
2021 Q3	$8.16M	Buy	170,878 +5,180	+3%	+$260K	2.68%	5
2021 Q2	$8.25M	Buy	165,698 +18,038	+12%	+$867K	2.8%	5
2021 Q1	$6.59M	Buy	147,660 +146,428	+11,885%	+$6.65M	2.48%	10
2020 Q4	$57K	Hold	1,232	–	–	0.02%	239
2020 Q3	$58K	Hold	1,232	–	–	0.02%	214
2020 Q2	$63K	Hold	1,232	–	–	0.03%	197
2020 Q1	$58K	Sell	1,232 -656	-35%	-$35K	0.03%	189
2019 Q4	$111K	Sell	1,888 -800	-30%	-$44.5K	0.03%	179
2019 Q3	$143K	Hold	2,688	–	–	0.05%	161
2019 Q2	$134K	Hold	2,688	–	–	0.05%	154
2019 Q1	$140K	Buy	2,688 +800	+42%	+$40K	0.06%	143
2018 Q4	$90K	Buy	+1,888	New	+$93K	0.04%	158
2017 Q2	–	Sell	-2,760	Closed	-$145K	–	186
2017 Q1	$145K	Buy	+2,760	New	+$140K	0.06%	137
2016 Q4	–	Sell	-2,688	Closed	-$145K	–	185
2016 Q3	$145K	Buy	2,688 +800	+42%	+$43.9K	0.06%	139
2016 Q2	$102K	Sell	1,888 -800	-30%	-$42.1K	0.04%	149
2016 Q1	$143K	Buy	+2,688	New	+$134K	0.06%	134
2015 Q2	–	Sell	-2,920	Closed	-$168K	–	186
2015 Q1	$168K	Sell	2,920 -1,274	-30%	-$73K	0.07%	128
2014 Q4	$224K	Hold	4,194	–	–	0.1%	120
2014 Q3	$241K	Hold	4,194	–	–	0.12%	110
2014 Q2	$280K	Hold	4,194	–	–	0.14%	109
2014 Q1	$280K	Hold	4,194	–	–	0.14%	105
2013 Q4	$280K	Hold	4,194	–	–	0.15%	103
2013 Q3	$263K	Hold	4,194	–	–	0.14%	101
2013 Q2	$262K	Buy	+4,194	New	+$266K	0.15%	99

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Clean Yield Group's GSK Position: Q1 2026 in Review

Clean Yield Group increased its GSK (GSK) stake by 0.38% in Q1 2026, buying an estimated $33.7K and bringing the position to 161,978 shares worth $8.94M. The position accounts for 2.52% of the portfolio, ranked #6.

Clean Yield Group first reported a position in GSK in Q2 2013 and has held it in 42 quarters since. The position peaked at $9.52M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Clean Yield Group held 161,978 shares of GSK worth $8.94M as of Q1 2026.
Clean Yield Group bought 621 GSK shares in Q1 2026, an estimated $33.7K.
GSK made up 2.52% of Clean Yield Group's portfolio in Q1 2026, its #6 holding.
Clean Yield Group first reported a position in GSK in Q2 2013 and has held it in 42 quarters since.
Clean Yield Group's GSK position peaked at $9.52M in Q4 2021.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.